Understanding how microglia affect glaucoma
Dissecting the complex role of microglia states in glaucoma
This study is looking at how certain immune cells in the brain, called microglia, might affect the damage to vision caused by glaucoma, with the hope of finding new ways to help protect your eyesight beyond just lowering eye pressure.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Rochester NIH-funded |
| Lab location | 1 site (Rochester, United States) |
| Project ID | NIH-11086080 on NIH RePORTER |
What this research studies
This research investigates the role of microglia, a type of immune cell in the brain, in the development and progression of glaucoma, a common age-related eye disease that leads to vision loss. The study aims to uncover the molecular mechanisms by which microglia contribute to the death of retinal ganglion cells, which are crucial for vision. By utilizing advanced sequencing technologies, researchers will explore the different states of microglia and how these states may either protect or harm retinal cells. This research could lead to new therapeutic strategies that go beyond current treatments focused solely on lowering eye pressure.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with glaucoma, particularly those experiencing vision loss.
Not a fit: Patients with glaucoma who are not experiencing any symptoms or vision loss may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to the development of neuroprotective treatments for glaucoma, potentially preserving vision for many patients.
How similar studies have performed: Previous research has shown that targeting microglial responses can be beneficial in other neurodegenerative diseases, suggesting a promising avenue for glaucoma treatment.
Where this research is happening
Rochester, United States
- University of Rochester — Rochester, United States (Active)
Researchers
- Principal investigator: Libby, Richard T — University of Rochester
- Study coordinator: Libby, Richard T
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.